# Continuous Application of Lisuride in Parkinson's Disease by Subcutaneous Infusion

> **NCT00408915** · PHASE3 · COMPLETED · sponsor: **Axxonis Pharma AG** · enrollment: 60 (estimated)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Continuous Subcutaneous Lisuride Infusion

## Key facts

- **NCT ID:** NCT00408915
- **Lead sponsor:** Axxonis Pharma AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2012-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00408915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00408915, "Continuous Application of Lisuride in Parkinson's Disease by Subcutaneous Infusion". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00408915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*